Fig. 1From: Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activationC-erbB-2 expression in EC and paracancerous tissues. Note: A. The expression of c-erbB-2 in EC tissues and paracancerous tissues detected by qRT-PCR; B: Immunohistochemical staining results of EC tissues and paracancerous tissues under high power microscope (× 400) (①paracancerous tissue; ② EC tissue); C: Positive expression rate of c-erbB-2 in EC tissues and paracancerous tissues detected by immunohistochemistry; D: The expression of IGF-1, IGF-1R and Akt in EC tissues and paracancerous tissues detected by qRT-PCR; *compared with paracancerous tissues, P < 0.05Back to article page